GANX stock

Gain Therapeutics Inc (GANX) valuation · $53.0M cap

Gain Therapeutics Inc (GANX) $53.0M cap.

Cached valuation scalars
MetricValue
Market cap$53.0M
Revenue$55.2K
P/S960.6
These valuation metrics as JSON? API free 100/day

GANX valuation FAQ

What is GANX's market cap?

Gain Therapeutics Inc (GANX) market cap is $53.0M on the latest cached fundamentals snapshot.

What is GANX's latest revenue?

Latest cached Gain Therapeutics Inc (GANX) revenue was $55.2K. Statements: https://lician.com/financials/ganx

What is GANX's price-to-sales ratio?

Gain Therapeutics Inc (GANX) price-to-sales (P/S) is 960.6, cached market cap $53.0M divided by revenue $55.2K.

How many GANX valuation scalars are listed on this page?

This page lists 3 cached valuation scalars for Gain Therapeutics Inc (GANX): Market cap, Revenue, and P/S.

Where is GANX valuation listed?

Cached valuation multiples for Gain Therapeutics Inc (GANX) are listed at https://lician.com/valuation/ganx.

Not investment advice. Cached rows, not a live tape.